Cite
HARVARD Citation
Tomcik, M. et al. (n.d.). SAT0025 Antifibrotic effects of imatinib mesylate are not superior to selective inhibition of PDGFR by ARRY-768 in preclinical models of dermal fibrosis. Annals of the rheumatic diseases. p. 479. [Online].